Transarterial Infusion of Pembrolizumab Plus <scp>TACE</scp> for Liver Metastases of Melanoma

This clinical experience represents the initial documentation of sequential intraarterial pembrolizumab followed by TACE in chemotherapy-resistant melanoma hepatic metastases. While a complete radiologic response was observed, conclusions regarding efficacy cannot be drawn from a single case. This approach appears feasible and warrants further study in well-designed clinical investigations.